Nutrition, obesity and hormones

  • Marco Giammanco | Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo; Research Unit in Endocrinology, Italian Society of Experimental Biology, Italy.
  • Laura Lantieri Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo; Research Unit in Endocrinology, Italian Society of Experimental Biology, Italy.
  • Gaetano Leto Department of Sciences for Health Promotion and Mother-Child Care, University of Palermo, Italy.
  • Fulvio Pescia Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo, Italy.
  • Danila Di Majo Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo, Italy.


Obesity is a chronic pathological condition with a multifactorial aetiology, characterised by an excessive body fat accumulation with multiple organ-specific consequences. Emerging evidence highlights that obesity appears to be associated with multiple alterations in the endocrine system. However, the mechanisms underlying the interactions between obesity and this system remain still controversial. This review discusses the impact of obesity on various endocrine systems and, in particular, would provide a general overview on the biochemical changes that may occur in each of these axes in association with obesity.



PlumX Metrics


Download data is not yet available.


Bastien M, Poirier P, Lwmieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014;56:369-81.

Bray GA, Kim KK, Wilding JPH. World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev 2017;18:715-23.

Poddar M, Chetty Y, Chetty, VT. How does obesity affect the endocrine system? A narrative review. Clin Obes 2017;7:136-44.

Panagiotis Kokkoris P, Pi-Sunyer X. Obesity and endocrine disease. Endocrinol Metab Clin N Am 2003;32:895-914.

Pedersen SD. Metabolic complications of obesity. Best Pract Res Clin Endocrinol Metab 2013;27:179-93.

Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999- 2004). Arch Intern Med 2008;168:1617-24.

Pasquali R, Vicennati V, Gambineri A, Pagotto U. Hormones and pathophysiology of obesity. Eat Weight Disord 2001;6:9-20.

Savastano S, Di Somma C, Mentone A. et al. GH insufficiency in obese patients. J Endocrinol Invest 2006;29:42-53.

Maccario M. Grottoli S, Procopio M, et al. The GH/IGF-I axis in obesity: influences of neuroendocrine and metabolic factors. Int J Obes Relat Disord 2000;24:S96-9.

Møller N, Gjedsted J, Gormsen L, et al. Effects of growth hormone on lipid metabolism in humans. Growth Horm IGF Res 2003;13:S18-21.

Scacchi M, Pincelli AI, Cavagnini F, et al. Growth hormone in obesity. Int J Obes Relat Metab Disord 1999;23:260-71.

Godenberg N, Barkan A. Factors regulating growth hormone secretion in humans. Endocrinol Metab Clin N Am 2007;36:37-55.

Broglio F, Benso A, Gottero C, et al. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol 2002;57:265-71.

Mazziotti G, Giustina A. Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol 2013;9:265-76.

Laron Z. Interactions between the thyroid hormones and the hormones of the growth hormone axis. Pediatr Endocrinol Rev 2003;12:244-50.

Paulo RC. Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men. J Clin Endocrinol Metab 2008;93:944-50.

Pombo M, Maccario M, Seoane LM, et al. Control and function of the GH-IGF-1 axis in obesity. Eat Weight Disord 2001;6:22-7.

Oscarsson J, Ottosson M, Eden S. Effects of growth hormone on lipoprotein lipase and hepatic lipase. J Endocrinol Invest 1999;22:2-9.

Oscarsson J, Ottosson M, Johansson JO, et al. Two Weeks of Daily Injections and Continuous Infusion of Recombinant Human Growth Hormone (Gh) in Gh-Deficient Adults. Ii. Effects on Serum Lipoproteins and Lipoprotein and Hepatic Lipase Activity. Metabolism 1996;45:370-7.

Jørgensen JO, Rubeck KZ, Nielsen TS, et al. Effects of GH in human muscle and fat. Pediatr Nephrol 2010;25:705-9.

Phillips LS, Unterman TG. Somatomedin activity in disorders of nutrition and metabolism. Clin Endocrinol Metab 1984;13:145-89.

Moller N, Vendelbo MH, Kampmann U, et al. Growth hormone and protein metabolism. Clinical Nutrition 2009;28:597-603.

Beauregard C, Utz AL, Schaub AE, et al. Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2008;93:2063-71.

Richelsen B. Effect of growth hormone on adipose tissue and skeletal muscle lipoprotein lipase activity in humans. J Endocrinol Invest 1999;22:10-15.

Vijayakumar A, Novosyadlyy R, Wu Y, et al. Biological Effects of Growth Hormone on Carbohydrate and Lipid Metabolism. Growth Horm IGF Res 2010;20:1-7.

Mauras N, O’Brien K, Welch S. et al. Insulin-Like Growth Factor I and Growth Hormone (Gh) Treatment in Gh-Deficient Humans: Differential Effects on Protein, Glucose, Lipid, and Calcium Metabolism. J Clin Endocrinol Metab 2000;85:1686-94.

Norrelund H, Riis AL, Moller N. Effects of GH on Protein Metabolism During Dietary Restriction in Man. Growth Horm IGF Res 2002;12:198-207.

Goldenberg N, Barkan A. Factors regulating growth hormone secretion in humans. Endocrinol Metab Clin North Am 2007;36:37-55.

van Vught AJ, Nieuwenhuizen AG, Brummer RJM, Westerterp-Plantenga MS. Effects of oral ingestion of amino acids and proteins on the somatotropic axis. J Clin Endocrinol Metab 2008;93:584-90.

Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of insulin-like growth factors. Endocr Rev 1994;15:80-101.

Yamamoto M, Iguchi G, Fukuoka H, et al. SIRT1 regulates adaptive response of the growth hormone-insulin-like growth factor-I axis underfasting conditions in liver. Proc Natl Acad Sci USA 2013;110:14948-53.

Livingstone C. Insulin-like growth factor-I (IGF-I) and clinical nutrition. Clin Sci 2013;125:265-80.

Michaelsen KF. Effect of protein intake from 6 to 24 months on insulin-like growth factor 1 (IGF-1) levels, body composition, linear growth velocity, and linear growth acceleration: what are the implications for stunting and wasting? Food Nutr Bull 2013;34:268-71.

Larnkjær A. Amberg K, Michaelsen KF, et al. Effect of milk proteins on linear growth and IGF variables in overweight adolescents. Growth Horm IGF Res 2014; 24:54-9.

Norat T, Dossus L, Rinaldi S, et al. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 2007;61:91-8.

Kaklamani VG, Linos A, Kaklamani E, et al. Dietary fat and carbohydrates are independently associated with circulating insulin like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations inhealthy adults. J Clin Oncol 1999;17:3291-8.

De Boer H. Blok GJ, Van Der Veen EA, et al. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63-86.

Newmann CB, Kleinberg DL. Adult growth hormone deficiency. The Endocrinologist 1998;8:178-86.

Vance ML, Mauras N. Growth hormone therapy in adults and children. N Engl J Med 1999;16:1206-16.

Carrol PV, Christ ER. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 1998;83:382-95.

Molitch ME, Clemmons DR, Malazowski S, et al. Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:1587-609.

Hartman ML, Crove BJ, Biller BMK, et al. HypoCCS Study Group Which patient do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002;87:477-85

Aimaretti G, Corneli G, Razzone P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998;83:1615-8.

Ghigo E. Diagnosis of adult GH deficiency. Growth Horm IGF Res 2008;18:1-16

Corneli G, Di Somma C, Bardelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 2005; 153:257-64.

Ghigo E, Aimaretti G, Arvat E, et al. Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine 2001;15:29-38.

Cordido F, Alvarez Castro P, Isidro ML, et al. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH- releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur J Endocrinol 2003;149:117-22.

Di Somma C, Savastano S, Rota F, et al. Appropriate use of stimulation tests and insulin-like growth factor-I in obesity. J Endocrinol Invest 2008;31:21-6.

Growth Hormone Research Society (GRS). Consensus guidelines for the diagnosis and treatment of adults with Growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency. J Clin Endocrinol Metab 1998;83:379-81.

Johansson AG, Engstrom BE, Ljunghall S, et al. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 1999;84:2002-7.

Nilsson AG, Svensson J, Johannsson G. Management of growth hormone deficiency in adults. Growth Horm IGF Res 2007;17:441-62.

Attanasio AF, Lamberts SWJ, Matranga AMC, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab 1997;82:82-8.

Colao A, Cerbone G, Pivonello R. et al. The growth hormone (GH) response to the arginine plus GH- releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. J Clin Endocrinol Metab 1999;84:1277-82.

Bengtsson BA, Edén S, Lönn L. et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-17.

Hoffman AR, Kuntze JE, Baptista J, et al. Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double- blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004;89:2048-56.

Chrisoulidou A, Beshyah SA, Rutherford O, et al. Effects of 7 years of growth hormone replacement. J Clin Endocrinol Metab 2000;85:3762-9.

Johannsson G, Grimby G, Sunnerhagen KS, Bengtsson BA. Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab 1997;82:2877-84.

Götherström G, Elbornsson M, Stibrant-Sunnerhagen K, et al. Ten years of growyh hormone replacement normalizes muscle strength in GH-deficient adults. J Clin Endocrinol Metab 2009;943:809-16.

Yang S, Cao L, Cai S, et al. A systematic review of growth hormone for hip fractures. Growth Horm IGF Res 2012;22:97-101.

Colao A, Di Somma C, Pivonello R, et al. Bone loss is correlated to the severity of growth hormone (GH) deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999;84:1919-24.

Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. The effect of long term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainance of peak bone mass. J Clin Endocrinol Metab 1996;81:3077-83

Colao A, di Somma C, Pivonello R, et al. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study. J Clin Endocrinol Metab 2002;87:1088-93

Colao A, Di Somma C, Spiezia, et al. Growth hormone treatment on atherosclerosis: results of a 5- year open, prospective, controlled study in male patients with severe growth hormone deficiency. J Clin Endocrinol Metab 2008;93:3416-24.

Costa-e-Sousa RH, Hollenberg AN. The neural regulation of the hypothalamic-pituitary-thyroid axis. Endocrinology 2012;153:4128-35.

Chiamolera MI, Wondisford FE. Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 2009;150:1091-6.

Scanlan TS1, Suchland KL, Hart ME, et al. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 2004;10:638-42.

Inada M, Nishikawa M. Thyroid hormone metabolism. Nihon Naibunpi Gakkai Zasshi 1993;69:9-15.

Chidakel A, Mentuccia D, Celi FS. Peripheral metabolism of thyroid hormone and glucose homeostasis, Thyroid 2005;8:899-903.

Debaveye Y, Ellger B, Mebis L, et al. Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness, Thyroid 2008;18:551-60.

Pujanek M, Bronisz A, Małecki P, Junik R. Pathomechanisms of the development of obesity in some endocrinopathies - an overview. Endokrynol Pol 2013;64:150-5.

Ghamari-Langroudi M, Vella KR, Srisai D, et al. Regulation of thyrotropin-releasing hormone- expressing neurons in paraventricular nucleus of the hypothalamus by signals of adiposity. Mol Endocrinol 2010;24:2366-81.

Rotondi M, Leporati P, La Manna A, et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol 2009;160:403-8.

Kok P, Roelfsema F, Langendonk JG et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab 2005;90:4659-63.

Reinehr T, Isa A, de Sousa G, et al. Thyroid hormones and their relationship to weight status. Horm Res 2008;70:51-7.

Mehran L, Amouzegar A, Delshad H, Azizi F. Association between serum TSH concentration and body mass index in euthyroid subjects: the role of smoking. Arch Iran Med 2012;15:400-3.

Knudsen N. Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005;90:4019-24.

Svare A, Nilsen TI, Bjoro T, et al. Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway. Clin Endocrinol 2011;74:769-75.

Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010; 316:165-71.

Michalaki M, Vagenakis AG, Argentou M, et al. Dissociation of thyrotropin and leptin secretion in acute surgical stress in severely obese patients. Obes Surg 2009;19:1424-9.

Mantzoros CS, Ozata M, Negrao AB, et al. Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab 2001;86:3284-91.

Gertig AM, Niechcial E, Skowronska B. Thyroid axis alterations in childhood obesity. Pediatr Endocrinol Diabetes Metab 2012;18:116-9.

Ren R, Jiang X, Zhang X, et al. Association between thyroid hormones and body fat in euthyroid subjects. Clin Endocrinol. 2014;80:585-90.

Ambrosi B, Masserini B, Iorio L, et al. Relationship of thyroid function with body mass index and insulin-resistance in euthyroid obese subjects. J Endocrinol Invest 2010;33:640-3.

Kok P, Roelfsema F, Langendonk JG, et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab 2005;90:4659-63.

Croxson MS, Hall TD, Kletzky OA, et al. Decreased serum thyrotropin induced by fasting. J Clin Endocrinol Metab 1977;45:560-8.

Lips MA, Pijl H, van Klinken JB, et al. Roux-en-Y gastric bypass and calorie restriction induce comparable time dependent effects onthyroid hormone function tests in obese female subjects. Eur J Endocrinol 2013;169:339-47.

Khan SM, Hamnvik OP, Brinkoetter M, Mantzoros CS. Leptin as a modulator of neuroendocrine function in humans. Yonsei Med J 2012 1;53:671-9.

Jonas W, Lietzow J, Wohlgemuth F. 3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary thyroid axis, body composition, and energy metabolism in male diet induced obese mice. Endocrinology 2015,156:389-99.

Giammanco M, Aiello S, Casuccio A, et al. Effects of 3,5-diiodo-L-thyronine on the liver of high fat diet fed rats. Journal of Biological Research 2016,89: 4-9.

Biondi B. Thyroid and Obesity: An Intriguing Relationship. J of Endocrinology and Metabolism 2010;95:3414-617

Tóth G, Noszál B. Thyroid hormones and their precursors I. Biochemical properties. Acta Pharm Hung 2013;832:35-45.

Oppenheimer JH. Thyroid today Editor: Volume 3, Number 7 November, 1980.

Leonard JL, Visser, TJ. (1986) Biochemistry of Deiodination. In : Thyroid Hormone Metabolism (Hennemann,G.,ed), pp 189-229. Marcel Dekker, New York;NY.

Spauling SW,Chopra IJ, Sherwin RS, Lyall SS. Effect of caloric restriction and dietary composition on serum T3 and rT3 in man. J Clin Endocrinol Metab 1976;42:197.

Glick Z, Wu SY, Lupien J, et al. Meal-induced brown fat thermogenesis and thyroid hormone metabolism in rats. Am J Physiol 1985;249:519-24.

Vagenakis A G, Portanay GI, O Brian JT, et al. Effect of starvation on the production and metabolism of thyroxine and triiodothyronine in euthyroid obese patients. J Clin Endocrinol Metab 1977;45,1305-09.

Harris AR, Fang SL, Azizi F, et al. Effect of starvation on hypothalamic-pituitary-thyroid function in the rat. Metabolism 1978;27:935-942.

Choi JW, Choi HS. The regulatory effects of thyroid hormone on the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Endocrine Research 2000;26:1-21.

Asvold BO, Vatten LJ, Nilsen TI, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. European Journal of Endocrinology 2007;156:181-6.

Wang F, Tan Y, Wang C, et al. Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones. J Clin Endocrinol Metab 2012;97:2724-31.

Asvold BO, Vatten LJ, Nilsen TI, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population- based study. The HUNT Study. Eur J Endocrinol 2007;156:181-6.

Eder K, Skufca P, Brandsch C. Dietary Fats Increase Plasma Thyroxine Concentrations in Rats Irrespective of the Vitamin E and Selenium Supply ; The Journal of Nutrition 2002;132:1275-81.

Burki TK. TSH, blood pressure, and lipid levels. Lancet Diabetes Endocrinol 2013;1:s12.

Araujo RL1, Andrade BM, Padrón AS, et al. High-fat diet increases thyrotropin and oxygen consumption without altering circulating 3,5,3'-triiodothyronine (T3) and thyroxine in rats: the role of iodothyronine deiodinases, reverse T3 production, and whole-body fat oxidation. Endocrinology 2010;151:3460-9.

Hoffman R, Gerber M. Evaluating and adapting the Mediterranean diet for non-Mediterranean populations: a critical appraisal. Nutr Rev 2013;71:573-84.

Castro-Quezada I, Román-Viñas B, Serra-Majem L. The Mediterranean diet and nutritional adequacy: a review. Nutrients 2014;6:231-48.

Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D. Mediterranean diet and metabolic syndrome: an updated systematic review. Rev Endocr Metab Disord 2013;14:255-63.

Sofi F, Cesari F, Abbate R, et al. Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008;337:a13144.

Baldini M, Pasqui F, Bordoni A, Maranesi M. Is the Mediterranean lifestyle still a reality? Evaluation of food consumption and energy expenditure in Italian and Spanish university students. Public Health Nutr 2009;12:148-55.

Sáez-Almendros S, Obrador B, Bach-Faig A, Serra-Majem L. Environmental footprints of Mediterranean versus Western dietary patterns: beyond the health benefits of the Mediterranean diet. Environ Health 2013 30;12:118.

Vasto S, Barera A, Rizzo C, et al. Mediterranean Diet And Longevity: An Example Of Nutraceuticals? Curr Vasc Pharmacol 2014;12:735-8.

Sofi F, Macchi C, Abbate R, et al. Mediterranean diet and health status: an updated meta- analysis and a proposal for a literature-based adherence score. Public Health Nutr 2013 Nov 29:1-14.

Funtikova AN, Benítez-Arciniega AA, Gomez SF, et al. Mediterranean diet impact on changes in abdominal fat and 10-year incidence of abdominal obesity in a Spanish population. Br J Nutr 2014;111:1481-7.

Bonaccio M, Di Castelnuovo A, Costanzo S, et al. Moli-sani Project Investigators Nutrition knowledge is associated with higher adherence to Mediterranean diet and lower prevalence of obesity. Results from the Moli-sani study. Appetite 2013;68:139-46.

Schröder H. Protective mechanisms of the Mediterranean diet in obesity and type 2 diabetes. J Nutr Biochem 2007;18:149-60.

Nadtochiy SM, Redman EK. Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition 2011;27:733-44.

Schröder H1, Marrugat J, Vila J, et al. Adherence to the traditional mediterranean diet is inversely associated with body mass index and obesity in a spanish population. J Nutr 2004;134:3355-61.

Chilliard Y, Ferlay A, Rouel J, Lamberet G. A review of nutritional and physiological factors affecting goat milk lipid synthesis and lipolysis. JDS 2003;86,1751-70.

Boelsma E, Kloek J. IPP-rich milk protein hydrolysate lowers blood pressure in subjects with stage 1 hypertension, a randomized controlled trial. Nutr J 2010;8;9:52.

Satija A, Agrawal S, Bowen L, et al. Association between milk and milk product consumption and anthropometric measures in adult men and women in India: a cross- sectional study. PLoS One 2013 8;8:e60739.

Kwon HT, Lee CM, Park JH, et al. Milk intake and its association with metabolic syndrome in Korean: analysis of the third Korea National Health and Nutrition Examination Survey (KNHANES III). J Korean Med Sci 2010;25:1473-9.

McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science 1984;224:1392-8.

Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J 2000;14:1132-8.

Newby PK, Muller D, Hallfrisch J, et al. Dietary patterns and changes in body mass index and waist circumference in adults. Am J Clin Nutr 2003;77:1417-25.

Rosell M, Håkansson NN, Wolk A. Association between dairy food consumption and weight change over 9 y in 19,352 perimenopausal women. Am J Clin Nutr 2006;84:1481-8.

Barba G, Troiano E, Russo P, et al. Inverse association between body mass and frequency of milk consumption in children. Br J Nutr 2005 ;93:15-9.

Marques-Vidal P1, Gonçalves A, Dias CM. Milk intake is inversely related to obesity in men and in young women: data from the Portuguese Health Interview Survey 1998-1999. Int J Obes 2006;30:88-93.

Gilbert JA1, Joanisse DR, Chaput JP, et al. Milk supplementation facilitates appetite control in obese women during weight loss: a randomised, single-blind, placebo-controlled trial. Br J Nutr 2011;105:133-43.

Zemel MB. Proposed role of calcium and dairy food components in weight management and metabolic health. Phys Sportsmed 2009;37:29-39.

Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. JCN 2002;21:146S-151S.

Zemel MB, Miller SL. Dietary calcium and dairy modulation of adiposity and obesity risk. Nutr Rev 2004;62:125-31.

Diersen-Schade DA, Richard MJ, Jacobson NL. Effects of dietary calcium and fat on cholesterol in tissues and feces of young goats. J Nutr 1984;114:2292-300.

Jacobsen R, Lorenzen JK, Toubro S, et al. Effect of shortterm high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. Int J Obes 2005;29:292-300.

Bendsen NT, Hother AL, Jensen SK, et al. Effect of dairy calcium on fecal fat excretion: a randomized crossover trial. Int J Obes 2008;32:1816-24.

Bush NC1, Alvarez JA, Choquette SS, et al. Dietary Calcium Intake Is Associated With Less Gain in Intra Abdominal Adipose Tissue Over 1 Year. Obesity 2010;18:2101-4.

Shi H, Dirienzo D, Zemel MB. Effects of dietary calsium on adipocyte lipid metabolism and body weight regulation in energy-restricted ap2-agouti transgenic mice. FASEB J 2000;8:291-330.

Cantó C, Houtkooper RH, Pirinen E, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 2012;15:838-47.

Major GC, Chaput JP, Ledoux M, et al. Recent developments in calcium-related obesity research. Obes Rev 2008;9:428-45.

Savastano S, Di Somma C, Belfiore A, et al. Growth hormone status in morbidly obese subjects and correlation with body composition. JEI 2006;29:536-43

Akanji AO, Smith RJ. The insulin-like growth factor system, metabolic syndrome, and cardiovascular disease risk. Metab Syndr Relat Disord 2012;10:3-13.

Lohr J, Grotevendt A, Nauck M, et al. Relation of insulin-like growth factor-I and IGF binding protein 3 with markers of inflammation: results of a population-based study. Clin Endocrinol 2014;80:148-54.

Makimura H. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab 2008;93:4254-60.

Ryan MC, Desmond P, Wilson A. Reply to: "might some of the beneficial effects of the Mediterranean diet on non-alcoholic fatty liver disease be mediated by reduced iron stores?". J Hepatol 2013;59:640.

Dreher ML. Pistachio nuts: composition and potential health benefits. Nutr Rev 2012;70:234-40.

National Institute of Research for Food and Nutrition (INRAN) - Food composition tables: dry walnuts.

European Food Safety Autority (EFSA) - Regulations (UE) n. 432/2012

Maguire LS, O'Sullivan SM, Galvin K, et al. Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr 2004;55:171-8.

Strahan TM. Nuts for cardiovascular protection. Asia Pac J Clin Nutr. 2004;13:S33.

Kris-Etherton PM, Yu-Poth S, Sabaté J,et al. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr. 1999;70:504-11.

Tapsell LC, Gillen LJ, Patch CS, et al. Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 2004;27:2777-83.

Gavin LA, Bui F, Mc-Mahon F, Cavallieri, RR. Sequential deiodination of thyroxine to 3-3 tiiodothyonine via 3,5,3 triiodothyronine and 3,3,5 triiodothyronine in rat liver homogenate:the effects of fasting versus glucose feeding. J Biol Chem 1980;254:49-54.

Danforth E, Horton ES, O'Connell M, et al. Dietary-induced Alterations in Thyroid Hormone Metabolism during Overnutrition. J Clin Invest. The American Society for Clinical Investigation 1979;64:1336-47.

Geoffrey J. Eales The Influence of Nutritional State on Thyroid Function in Various Vertebrates. Oxford Journals Life Sciences Integrative and Comparative Biology 2011;20: 351-62.

Suda AK, Pittman CS, Shimizu T, Chambers JB. The production and metabolism of 3,5,3'- triiodothyronine and 3,3',5-triiodothyronine in normal and fasting subjects. J Clin Endocrinol Metab 1978;7:1311-131.

Schwartz HL, Lancer SR, Oppenheimer JH. Thyroid hormones influence starvation-induced hepatic protein loss in the rat: possible role of thyroid hormones in the generation of labile. Endocrinology 2013;107:1684-92.

Tabacchi G, Giammanco S, La Guardia M, Giammanco M. A review of the literature and a new classification of the early determinants of childhood obesity: from pregnancy to the first years of life. Nutrition Research 2007;27:587-604.

La Guardia M, Giammanco M, Breast cancer and obesity. Panminerva Medica. 2001;42:123-33.

Review Articles
obesity, growth hormone, thyroid hormones, endocrine system, nutrition
  • Abstract views: 1396

  • PDF: 510
How to Cite
Giammanco, M., Lantieri, L., Leto, G., Pescia, F., & Di Majo, D. (2018). Nutrition, obesity and hormones. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 91(2).